Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.

Abstract

Over the past decade, a series of clinical reports have described the experience of Down syndrome (DS) children treated for acute myeloid leukemia (AML). Whereas prior to the first reports in the early 1980's it was felt that DS children with AML had poor outcomes, these clinical trials concluded that DS had a better outcome than non-DS (NDS) children with… (More)

Topics

Cite this paper

@article{Gamis2005AcuteML, title={Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.}, author={Alan S Gamis}, journal={Pediatric blood & cancer}, year={2005}, volume={44 1}, pages={13-20} }